The US Food and Drug Administration (FDA) is warning physicians that data from both clinical and industry sources suggests that the occurrence of Type III endoleaks in patients who have undergone ...
A lone endovascular graft system for use in EVAR procedures is responsible for the increased rates of Type III endoleaks that have been of concern to the US Food and Drug Administration (FDA) for the ...
Endovascular aneurysm repair is a minimally invasive technique for the treatment of abdominal aortic aneurysms—life-threatening bulges in the aorta's abdominal section. However, it carries the risk of ...
SILVER SPRING, MD — There appears to have been an increase in type IIIa and IIIb endoleaks with endovascular graft systems used for endovascular aneurysm repair (EVAR), the US Food and Drug ...
Dr. Matt Thompson, Chief Medical Officer of Endologix Inc. commented, “On September 28, 2017, the FDA issued a letter to health care professionals (“HCPs”) regarding Type III endoleaks after ...
Please provide your email address to receive an email when new articles are posted on . The FDA’s Circulatory System Devices Panel advised that for a stent graft system to treat patients with ...
Endovascular aneurysm repair is a minimally invasive technique for the treatment of abdominal aortic aneurysms—life-threatening bulges in the aorta's abdominal section. However, it carries the risk of ...
Endoleak is a frequent complication after endovascular aortic repair and is a risk factor for spontaneous rupture of aneurysm. Administration of thrombolytics in patients with known abdominal aortic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results